MSB 4.07% $1.15 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-113

  1. 1,449 Posts.
    lightbulb Created with Sketch. 3160
    Hi @WesM,

    that's the point. Do read the 'Footnotes'. Heh.

    WHAT IS ALREADY KNOWN ON THIS TOPIC
    Parachutes are routinely used to prevent death or major traumatic injury among
    individuals jumping from aircraft, but their efficacy is based primarily on
    biological plausibility and expert opinion
    No randomized controlled trials of parachute use have yet been attempted,
    presumably owing to a lack of equipoise

    WHAT THIS STUDY ADDS
    This randomized trial of parachute use found no reduction in death or major
    injury compared with individuals jumping from aircraft with an empty backpack
    Lack of enrolment of individuals at high risk could have influenced the results of
    the trial


    Cheers
    Last edited by Phaedrus: 23/11/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.